Anti-SPRE2/ SPRED2/ Spred-2 monoclonal antibody

Anti-SPRE2/ SPRED2/ Spred-2 antibody for FACS & in-vivo assay

Target products collectionGo to SPRED2/SPRED2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1706-Ab-1/ GM-Tg-hg-MP1706-Ab-2Anti-Human SPRED2 monoclonal antibodyHuman
GM-Tg-rg-MP1706-Ab-1/ GM-Tg-rg-MP1706-Ab-2Anti-Rat SPRED2 monoclonal antibodyRat
GM-Tg-mg-MP1706-Ab-1/ GM-Tg-mg-MP1706-Ab-2Anti-Mouse SPRED2 monoclonal antibodyMouse
GM-Tg-cynog-MP1706-Ab-1/ GM-Tg-cynog-MP1706-Ab-2Anti-Cynomolgus/ Rhesus macaque SPRED2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1706-Ab-1/ GM-Tg-felg-MP1706-Ab-2Anti-Feline SPRED2 monoclonal antibodyFeline
GM-Tg-cang-MP1706-Ab-1/ GM-Tg-cang-MP1706-Ab-2Anti-Canine SPRED2 monoclonal antibodyCanine
GM-Tg-bovg-MP1706-Ab-1/ GM-Tg-bovg-MP1706-Ab-2Anti-Bovine SPRED2 monoclonal antibodyBovine
GM-Tg-equg-MP1706-Ab-1/ GM-Tg-equg-MP1706-Ab-2Anti-Equine SPRED2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1706-Ab-1/ GM-Tg-hg-MP1706-Ab-2; GM-Tg-rg-MP1706-Ab-1/ GM-Tg-rg-MP1706-Ab-2;
GM-Tg-mg-MP1706-Ab-1/ GM-Tg-mg-MP1706-Ab-2; GM-Tg-cynog-MP1706-Ab-1/ GM-Tg-cynog-MP1706-Ab-2;
GM-Tg-felg-MP1706-Ab-1/ GM-Tg-felg-MP1706-Ab-2; GM-Tg-cang-MP1706-Ab-1/ GM-Tg-cang-MP1706-Ab-2;
GM-Tg-bovg-MP1706-Ab-1/ GM-Tg-bovg-MP1706-Ab-2; GM-Tg-equg-MP1706-Ab-1/ GM-Tg-equg-MP1706-Ab-2
Products NameAnti-SPRED2 monoclonal antibody
Formatmab
Target NameSPRED2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SPRED2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species SPRE2/ SPRED2/ Spred-2 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP002193human SPRED2 Lentivirus plasmid
    ORF Viral VectorvGMLP002193human SPRED2 Lentivirus particle
    ORF Viral VectorpGMLPm002329mouse Spred2 Lentivirus plasmid
    ORF Viral VectorvGMLPm002329mouse Spred2 Lentivirus particle


    Target information

    Target IDGM-MP1706
    Target NameSPRED2
    Gene ID200734,114716,305539,697196,481397,101092176,519081,100062947
    Gene Symbol and SynonymsNS14,Spred-2,SPRED2
    Uniprot AccessionQ7Z698,Q3C2P8
    Uniprot Entry NameSPRE2_HUMAN,SPRE2_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000198369
    Target ClassificationN/A

    The target: SPRED2, gene name: SPRED2, also named as Spred-2. SPRED2 is a member of the Sprouty (see SPRY1; MIM 602465)/SPRED family of proteins that regulate growth factor-induced activation of the MAP kinase cascade (see MAPK1; MIM 176948) (Nonami et al., 2004 [PubMed 15465815]).[supplied by OMIM, Mar 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.